| First Author | Sukka SR | Year | 2024 |
| Journal | Nat Metab | Volume | 6 |
| Issue | 9 | Pages | 1736-1755 |
| PubMed ID | 39242914 | Mgi Jnum | J:360255 |
| Mgi Id | MGI:7797648 | Doi | 10.1038/s42255-024-01115-7 |
| Citation | Sukka SR, et al. (2024) Efferocytosis drives a tryptophan metabolism pathway in macrophages to promote tissue resolution. Nat Metab 6(9):1736-1755 |
| abstractText | Macrophage efferocytosis prevents apoptotic cell (AC) accumulation and triggers inflammation-resolution pathways. The mechanisms linking efferocytosis to resolution often involve changes in macrophage metabolism, but many gaps remain in our understanding of these processes. We now report that efferocytosis triggers an indoleamine 2,3-dioxygenase-1 (IDO1)-dependent tryptophan (Trp) metabolism pathway that promotes several key resolution processes, including the induction of pro-resolving proteins, such interleukin-10, and further enhancement of efferocytosis. The process begins with upregulation of Trp transport and metabolism, and it involves subsequent activation of the aryl hydrocarbon receptor (AhR) by the Trp metabolite kynurenine (Kyn). Through these mechanisms, macrophage IDO1 and AhR contribute to a proper resolution response in several different mouse models of efferocytosis-dependent tissue repair, notably during atherosclerosis regression induced by plasma low-density lipoprotein (LDL) lowering. These findings reveal an integrated metabolism programme in macrophages that links efferocytosis to resolution, with possible therapeutic implications for non-resolving chronic inflammatory diseases, notably atherosclerosis. |
